He’s well-known to boxing enthusiasts. However, if you aren’t a fan of boxing, you might not be familiar with Daniel Jacobs. This boxing professional has won the middleweight world title twice. Not merely because of his incredible physical accomplishments, his story is one that deserves to be known. Daniel Jacobs has also battled cancer.
Daniel received the diagnosis of osteosarcoma, a rare and severe bone cancer, in 2011. His spine’s nerves were harmed by it. His legs were partially paralyzed as a result. His ability to walk again was unknown to the doctors. Daniel, though, recovered fully in less than two years. The World Boxing Association and the International Boxing Federation later awarded him championship titles. The Miracle Man is his nick name.
Recognizing Daniel’s story now seems appropriate because July is Sarcoma and Bone Cancer Awareness Month. It’s also a good moment to discuss bone cancer, risk factors, and available treatments.
Metastasis, or the transfer of cancer from another part of the body to the bone, is a common cause of bone cancer. There are also primary malignancies of the bone, such as the osteosarcoma found in Daniel Jacobs. It is not very common to get primary bone cancer. Every year, 2 out of every 1,000 new cases of cancer in the United States are due to it.
There are various forms of bone cancer, which vary depending on where they develop:
- The most prevalent form of bone cancer is osteosarcoma. The knee or upper arm are frequent locations.
- In cartilaginous tissue, chondrosarcoma first appears. It may have several characteristics that alter the prognosis. Dedifferentiated chondrosarcoma, clear cell chondrosarcoma, and mesenchymal chondrosarcoma are three examples of the prognosis.
- The backbone, pelvis, arms, or legs are the areas of the body where Ewing sarcoma most frequently develops.
- Instead of the bones, malignant fibrous histiocytoma frequently begins in the soft tissue (connective tissue). It affects the arms or legs and spreads fast to other regions of the body when it forms in the bones.
- Both benign and malignant giant cell tumors of the bone can arise, but malignant forms are incredibly uncommon.
- A tumor known as a chordoma can develop at the base of the skull or the vertebrae in the spine. It develops slowly and frequently does not extend to other bodily regions. It will, however, reappear in the same place if it is not deleted.
In the United States, it’s anticipated that more than 13,000 cases of soft tissue sarcoma and around 3,600 instances of bone sarcoma would be identified in 2021.
Surveillance, Epidemiology and End Results Program of the National Cancer Institute
Scientists are discovering more about the causes of bone cancer, which is contributing to our growing understanding of the disease. The following are typical illness risk factors:
- genetic conditions like the Multiple Exostoses Syndrome, the Rothmund-Thomson Syndrome, and the Li-Fraumeni Syndrome.
- exposure to radiation or radioactive substances like strontium and radium. Due to mineral buildup in the bones, this may result in bone cancer.
The type of bone cancer you have, its stage, your general health, and your personal preferences will all affect your treatment options. If you have any questions about your therapy or the phrases your healthcare providers are using, don’t hesitate to ask them.
Prior to starting therapy, it is beneficial to be aware of any adverse effects and symptoms. To help control common side effects like nausea, diarrhea, constipation, and mouth sores, there are effective and easily accessible drugs. Remember that every person responds to treatment in a unique way. Talk to your healthcare practitioner if you notice any side effects.
Bone cancer treatment options include:
- Surgery the main method of treating bone cancer. In order to ensure that no further cancer cells are discovered at the edge or border of the tissue removed, the tumor must be completely eliminated.
- Cryosurgery
- the freezing and killing of cancer cells with liquid nitrogen.
- Chemotherapy is a systemic (whole-body) treatment approach that uses medications to eradicate cancer cells. Patients with bone cancer typically get a cocktail of chemotherapy medications. Ewing sarcoma and osteosarcoma are frequently treated with chemotherapy, although other bone malignancies like chondrosarcoma are rarely treated with it.
- radiation treatment
- the destruction or damage of cancer cells with high-energy radiation. Surgery and this treatment could be combined. It is frequently employed to treat chondrosarcoma, which cannot be surgically treated. It may also be used in conjunction with chemotherapy and potentially surgery to treat Ewing sarcoma.
In This Article...
What hue represents bone cancer on a ribbon?
Sarcoma or bone cancer is symbolized by a yellow ribbon. Bone cancer comes in a variety of forms. Sarcoma can affect the body’s connective tissues, including the cartilage and myofascial tissue, as well as the bones.
Organizations like the Sarcoma Foundation of America support funding for research and raise public awareness of the condition.
Which months are designated as cancer awareness months?
Calendar for Cancer Awareness Month
- Week of Cervical Cancer Prevention in January.
- February. Awareness of esophageal cancer. Day Against Cancer.
- March. Awareness of colorectal cancer. Awareness of ovarian cancer. Awareness of brain tumors. Awareness of prostate cancer.
What represents bone cancer?
For fundraising activities, the yellow ribbon is utilized as a representation of bone cancer. One method to raise awareness and express support for bone cancer survivors and their caregivers is to wear a yellow ribbon. July is also recognized as Bone Cancer Awareness Month.
What is the bone cancer survival rate?
THIS PAGE CONTAINS INFORMATION REGARDING THE NUMBER OF PEOPLE WHO RECEIVE A BONE SARCOMA DIAGNOSIS EACH YEAR. Additionally, you’ll learn general information on battling the illness. Keep in mind that a number of factors affect survival rates. To view additional pages, use the navigation.
Primary bone sarcoma is a type of cancer that originates in the bone, as stated in the Introduction. Primary bone sarcomas make up less than 1% of all malignancies. Adults are far more likely to have cancer that has progressed to their bones from another part of their body. The numbers listed below pertain to primary bone sarcoma.
In the United States, primary bone sarcoma will be diagnosed in an expected 3,910 people of all ages (2,160 men and boys and 1,750 women and girls). 400 of these cases were predicted to occur in people between the ages of 15 and 19 in 2020.
In the United States, it is anticipated that this disease will cause 2,100 deaths this year (1,180 deaths in men and boys and 920 deaths in women and girls).
The majority of primary bone sarcomas in adults are chondrosarcomas. Osteosarcoma, chordoma, and Ewing sarcoma are the next most frequent types of bone sarcoma in adults. The remaining bone sarcoma varieties are uncommon.
Osteosarcoma and Ewing sarcoma are diagnosed far more frequently in adolescents and children than chondrosarcoma and other bone tumors.
The percentage of persons who survive at least 5 years after their cancer is discovered is shown by the 5-year survival rate. Percentage refers to the number out of 100. The type and stage of bone sarcoma that is detected affects survival rates in the United States, among other things.
People with chordoma had an 82 percent 5-year survival rate. The 5-year survival rate is 87% if cancer is discovered at a localized stage. The 5-year survival rate is 83% if the disease has progressed to the local lymph nodes, adjacent tissues, or organs. The 5-year survival rate is only 55% if the cancer has migrated to distant body areas.
Chondrosarcoma comes in a variety of forms. Some grow slowly (low grade), whereas others grow more quickly (high grade). The rates listed here are the average for all chondrosarcoma types. People with chondrosarcoma had a 78 percent 5-year survival rate. The 5-year survival rate is 91% if cancer is discovered at a localized stage. The 5-year survival rate is 75% if the cancer has spread to nearby tissues or organs and/or the local lymph nodes. The 5-year survival rate is 22% if the cancer has migrated to distant body parts.
Ewing sarcoma patients have a 61 percent 5-year survival rate. The 5-year survival rate is 81 percent if cancer is discovered at a localized stage. The 5-year survival rate is 67 percent if the cancer has spread to nearby tissues, organs, and/or local lymph nodes. The 5-year survival rate is 38% if the cancer has progressed to distant areas of the body.
People with osteosarcoma have a 60% 5-year survival rate. The 5-year survival rate is 74% if cancer is discovered at a localized stage. The 5-year survival rate is 66% if the cancer has progressed to the local lymph nodes, adjacent tissues, or organs. The 5-year survival rate is 27% if the cancer has progressed to distant areas of the body.
It’s critical to keep in mind that estimates of the survival rates for persons with bone sarcoma might vary widely based on a number of variables. It is crucial to speak openly about this with your doctor. The estimate is based on annual data on the number of Americans who have this cancer. Additionally, every five years, experts measure the survival rates. This means that the estimate might not account for improvements in the last five years in the diagnosis or treatment of bone sarcoma. If you have any questions concerning this material, consult your doctor. Find out more about how to comprehend statistics.
The American Cancer Society’s (ACS) publications Cancer Facts & Figures 2022 and Cancer Facts & Figures 2020, as well as the ACS website, were used to compile the statistics. (Accessed January 2022 for all sources.)
What are the chances of developing bone cancer?
Bone cancer is frequently effectively treated. In such cases, cancer never reappears. To achieve this result, patients might require numerous operations.
To prevent the disease from spreading, additional patients with bone cancer may need to continue receiving chemotherapy and radiation therapy. To control cancer, these treatments could last eternally.
It’s critical to follow up with your doctor on a frequent basis to search for symptoms of cancer recurrence or spread. Your physician can begin treating a recurrence as soon as it is discovered.
Is bone cancer usually fatal?
Not typically. Bone cancer will cause some people to pass away, but many more people will fully recover. The relative survival rate for bone cancer at five years is 66.8%. This indicates that 66.8% of those who are diagnosed with bone cancer survive five years after their diagnosis. Remember that survival numbers are simply approximations based on patients who have already had bone cancer. They are unable to foretell your lifespan or the specifics of your circumstance. Speak with your healthcare physician to learn more about the survival statistics for bone cancer.
How long can you live with bone cancer?
Many patients who are diagnosed with bone cancer receive excellent therapy and go on to have happy lives. A full recovery is more likely for those with early-stage bone cancer. Survival rates drop when bone cancer is discovered later.
September is cancer awareness month.
September is Blood Cancer Awareness Month, when supporters and advocates of The Leukemia & Lymphoma Society (LLS) focus on raising awareness about our efforts to combat blood cancers like leukemia, lymphoma, myeloma, and Hodgkin’s disease both locally and nationally.
November is cancer awareness month, right?
Rare, slow-growing malignancies known as carcinoid tumors typically begin in the lining of the digestive tract and lungs, however they can also develop in the testes and ovaries. These tumors start in the cells of the neurological and hormonal systems and are a kind of neuroendocrine tumor growth.
Early-stage carcinoid cancer frequently shows no symptoms, and it is frequently unintentionally identified on an X-ray for a different reason.
Carcinoid tumors can cause symptoms like facial flushing, diarrhea, abdominal pain, rash, and intestinal bleeding, which are not particular to this illness. Most cases of this kind of cancer are found in patients over the age of 60. Women are more likely than men to develop carcinoid cancer. In the US, carcinoid tumors are identified in more than 12,000 persons annually.
Atrophic gastritis, pernicious anemia, and Zollinger-Ellison syndrome are conditions that affect the stomach’s ability to produce stomach acid and are risk factors for carcinoid cancers. Other risk factors include having a family history of multiple endocrine neoplasia type 1 (MEN1) syndrome or neurofibromatosis type 1 (NF1) syndrome.
Exists a national cancer awareness month?
National Cancer Prevention Month is in February. Review our website’s other resources, download A Guide to Preventing Cancer, and have a look at our Seven Steps to Prevent Cancer.
What type of bone cancer is the rarest?
Adamantinoma. Rare bone cancer known as adamantinoma nearly often affects the bones in the lower leg. Of all bone sarcomas, adamantinomas make up less than 1%.
